Gordana Vlahovic

Journal Article JAMA Oncol · October 1, 2019 IMPORTANCE: New therapeutic options for patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) are needed. This study evaluated dual checkpoint combination therapy in patients with mPDAC. OBJECTIVE: To evaluate the safety and efficacy of the ant ... Full text Link to item Cite

A phase 3 study of durvalumab with or without bevacizumab as adjuvant therapy in patients with hepatocellular carcinoma (HCC) who are at high risk of recurrence after curative hepatic resection.

Journal Article Ann Oncol · July 2019 Full text Link to item Cite

A phase 3 study of durvalumab with or without bevacizumab as adjuvant therapy in patients with hepatocellular carcinoma at high risk of recurrence after curative hepatic resection or ablation: EMERALD-2.

Journal Article Ann Oncol · July 2019 Full text Link to item Cite

View All Publications

Recent Grants

Brain tumors with regulatory T-cells treated with EGFRvIII-specific T-cells

ResearchInvestigator · Awarded by National Institutes of Health · 2013 - 2018

Mentored Clinical Research Scholar Program

ResearchFaculty Associate · Awarded by National Institutes of Health · 2002 - 2006

View All Grants

Education, Training & Certifications

University of Zagreb (Croatia) · 1985 M.D.